BioCryst (BCRX) Sees Upside; No Poultry Contact Reported in Large Amount of Bird Flu Cases
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
BioCryst (BCRX) Moves Higher as WHO Calls H7N9 'Most Lethal' Bird Flu Strain
April 24, 2013 10:36 AM EDTBioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) is trading higher once again today following commentary out of the World Health Organization (WHO) earlier.
One expert from the WHO said that the H7N9 is "one of the most lethal" strains of the bird... More
BioCryst Pharma (BCRX) Rally Overdone, Says Analyst
April 8, 2013 2:49 PM EDTShares of BioCryst Pharma (Nasdaq: BCRX) climbed Monday morning. The move is tied to reports China was expediting approval of intravenous anti-flu drug permivir to satisfy demand related to a recent outbreak of bird flu, which killed 6 people.
Commenting on developments,... More
